Equities

Hi-Great Group Holding Co

HIGR:PKC

Hi-Great Group Holding Co

Actions
  • Price (USD)0.0178
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 29 2024 17:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hi-Great Group Holding Company is a development stage company. The Company focuses on the distribution of plant-based finished consumer products and integrating the use of specialty herbs into its worldwide health supplement business to include expansion into the cosmetics sector using multiple herbal oils and compounds. It plans to grow organically through Internet sales of its worldwide exclusive license agreement with SellaCare, Inc. in the areas of longevity health supplements and plans to integrate new product lines containing cannabidiol (CBD) oils for additional health benefits and also expand into the cosmetic sector.

  • Revenue in USD (TTM)71.99k
  • Net income in USD-74.35k
  • Incorporated2010
  • Employees--
  • Location
    Hi-Great Group Holding Co621 S. Virgil Ave #470LOS ANGELES 90005United StatesUSA
  • Phone+1 (213) 219-7746
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Regen BioPharma Inc236.57k-882.60k1.35m1.00------5.72-0.2157-0.21570.0594-1.181.04--3.82236,570.00-407.33-104.36---------392.01-275.00---1.36----0.441618.79-58.11------
Aditxt Inc329.75k-43.31m1.38m47.00--0.1162--4.18-77.20-77.200.3033.290.01850.60820.83937,015.96-242.33-192.78-1,548.63-321.59-46.09---13,105.77-7,208.650.0458-3.530.5084---30.90---18.11------
Seelos Therapeutics Inc2.01m4.09m1.40m8.000.0205----0.69419.769.761.43-8.470.2823--6.51134,266.7057.34-180.05---386.76----203.13-9,612.88---608.33--------48.48------
Aclarion Inc53.95k-5.90m1.60m6.00--0.885--29.64-4.74-4.740.01460.200.0212--3.598,991.67-231.70---714.18---51.53---10,937.05-----111.150.3212--24.75--34.38------
Panbela Therapeutics Inc0.00-28.56m1.65m7.00---------84.64-84.640.00-2.180.00----0.00-197.23-215.89-3,522.07-476.38-----------143.57--------27.68------
Hi-Great Group Holding Co71.99k-74.35k1.78m--------24.73-0.0007-0.00070.0007-0.00130.71490.627-----73.83------51.28---103.28--0.0099-20.74-----47.32---3,789.70------
Axim Biotechnologies Inc92.90k-4.14m1.81m6.00------19.50-0.0163-0.01630.0003-0.03240.0233----15,483.33-103.73-154.34---390.7316.94---4,451.97-36,362.71---3.14----345.05-27.38-29.10------
Pharmagreen Biotech Inc1.56k-500.66k1.92m0.00------1,233.70-0.0011-0.00110.00-0.00450.0094--3.35---302.10-472.20----11.54---32,096.15--0.0194-71.71--------80.68------
Cyclacel Pharmaceuticals Inc80.00k-17.61m1.93m12.00--1.77--24.18-16.14-16.140.04230.55340.0065--0.0547---142.14-57.58-327.21-69.81-----21,882.50-18,789.29---100.520.00----22.87-6.34---31.23--
Novelstem International Corp18.00k-1.65m1.97m15.00------109.39-0.0352-0.03520.0004-0.05410.0081--8.00---63.77-----------7,867.33-----2.132.61--0.00---446.84------
180 Life Sciences Corp0.00-12.55m2.02m4.00---------28.16-28.160.00-0.44390.00----0.00-142.80-42.39-270.23-56.41------------18.20------48.52------
VG Life Sciences Inc0.00-4.30m2.11m7.00---------0.0721-0.07210.00-0.04910.00-------384.41-294.08-----------587,591.90---1.70--------16.58------
Kiromic Biopharma Inc0.00-26.21m2.20m35.00---------19.73-19.730.00-3.350.00----0.00-167.49-161.04---294.57-----------7.221.74------33.00--8.52--
Data as of Jul 29 2024. Currency figures normalised to Hi-Great Group Holding Co's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.